On January 21, 2025, the Food and Drug Administration sanctioned treosulfan (Grafapex, medac GmbH), an alkylating agent, in conjunction with fludarabine as a preparative regimen for allogeneic hematop...
hematopoietic-stem-cell-transplantation
IntroductionHematological malignancies, such as leukemias, lymphomas, and multiple myeloma, are a heterogeneous group of cancers that arise in the bone marrow and lymphatic system. Conventional trea...
hematopoietic-stem-cell-transplantation
IntroductionCancer is still one of the most difficult diseases to cure, and conventional treatments such as chemotherapy, radiation, and surgery have yielded limited success and severe side effects....
hematopoietic-stem-cell-transplantation
March 2022: Abatacept (Orencia, Bristol-Myers Squibb Company) has been approved by the Food and Drug Administration for the prevention of acute graft versus host disease (aGVHD) in adults and paediat...
hematopoietic-stem-cell-transplantation
hematopoietic-stem-cell-transplantation
hematopoietic-stem-cell-transplantation
Beijing Lu Daopei Hospital, situated in the Beijing economic and technological development area, spans a substantial 27,000 square meters with 300 beds and 36 air laminar flow rooms. Renowned as the b...
hematopoietic-stem-cell-transplantation